| Literature DB >> 35807028 |
Mohammad Khalid1, Mohammed H Alqarni1, Shadma Wahab2, Sivakumar Annadurai2, Mubarak A Alamri3, Ahmed I Foudah1, Tariq M Aljarba1, Juber Akhtar4, Sarfaraz Ahmad5.
Abstract
The ethanolic extracts of Spondias mangifera fruit (SMFE) were evaluated for aphrodisiac activity. The in-vitro phosphodiesterase-5 (PDE-5) inhibition was assessed based on in-silico molecular docking and simulation studies. In addition, the in-vivo sexual behavior was analyzed in the form of mount (MF, ML), intromission (IF, IL), and ejaculation (EF, EL) frequencies and latencies to validate the in-vitro results. Some biochemical parameters, including PDE-5, nitric oxide, and testosterone, were also observed. The above extract constituted β-amyrin, β-sitosterol, and oleanolic acid and showed tremendous binding with phosphodiesterase-5 and sildenafil. Both the sildenafil and ethanolic extracts (200 and 400 mg/kg/d bodyweight) significantly (p < 0.1, p < 0.05) increased MF, IF, and EF, respectively. In contrast, ML and IL significantly (p < 0.1) decreased, and EL significantly (p < 0.1) increased compared with a normal group of animals. The ethanolic extracts (200 and 400 mg/kg/d bodyweight) and sildenafil further significantly (p < 0.05, p < 0.1) diminished PDE-5 activity significantly (p < 0.05, p < 0.1) and enhanced nitric oxide and testosterone levels, as compared with normal rodents. Therefore, the S. mangifera ethanolic extract might be a valuable alternate aphrodisiac for erectile dysfunction.Entities:
Keywords: S. mangifera; aphrodisiac; ejaculation; impotency; in-silico; mount frequency; phosphodiesterase-5
Year: 2022 PMID: 35807028 PMCID: PMC9267661 DOI: 10.3390/jcm11133732
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Summary of the selected constituents and the reference compound sildenafil into the active site of PDE-5, chemical structures, AutoDock vin docking scores, hydrogen bond interactions, and close contact residues.
| Ligands | Chemical Structure | Binding Energy Score (kcal/mol) | H-Bond Interaction | Hydrophobic Interaction |
|---|---|---|---|---|
| Sildenafil |
| −10.01 | ARG A: 667, | HIS A: 613, LEU A: 725, LEU A: 765, ALN A: 765, TYR A: 612, |
| Oleanolic acid |
| −10.51 | SER A: 663 | LEU A: 765, LEU A: 725, ILE A: 824, PHE A: 820, ALA A: 823, |
| β-sitosterol |
| −9.90 | -- | LEU A: 765, LEU A: 725, |
| β-amyrin |
| −11.61 | MEH A: 816 | ARG A: 667, ASN A: 661, |
Summary of the selected constituents and the reference compound sildenafil into the active site of dopamine R2, chemical structures, AutoDock vin docking scores, hydrogen bond interactions, and close contact residues.
| Ligands | Chemical Structure | Binding Energy Score (kcal/mol) | H-Bond Interaction | Hydrophobic Interaction |
|---|---|---|---|---|
| Sildenafil |
| −9.2 | ASP A: 114 | PRO A: 405, SERA: 409, TRPA: 413, PHEA: 110, LEUA: 94, TRPA: 100, THRA: 412, VAL A: 91, TYR A: 416, VAL A: 115, SER A: 193, |
| Oleanolic acid |
| −8.6 | TYR A: 213 | ASP A: 1072, TYR A: 1088, ALA A: 1093, |
| β-Sitosterol |
| −8.9 | -- | VAL A: 91, TRP A: 413, GLU A: 95, LEU A: 94, |
| β-Amyrin |
| −8.6 | TRP A: 413, VAL A: 91, LEU A: 94, SER A: 409, THR A: 412, TYR A: 402, ASN A: 396, |
Figure 1(A) Two-dimensional representation of the docked conformation of PDE-5 with ligands obtained after AutoDock vin docking. Green dashed lines represent conventional hydrogen bonds with the interacting amino acid residues. Pink lines indicate interactions between hydrophobic (alkyl–alkyl, π–alkyl or π–π). (B) Three-dimensional representation of the docked conformation of the PDE-5 representation of docked conformation with ligands obtained after docking.
Figure 2(A) Two-dimensional representation of the docked conformation of dopamine R2 with ligands obtained after docking. Green dashed lines represent conventional hydrogen bonds with the interacting amino acid residues. Pink lines indicate interactions between hydrophobic (alkyl–alkyl, π–alkyl, or π–π). (B) Three-dimensional representation of the docked conformation of dopamine R2 docked conformation of ligands obtained after Glide XP docking.
Figure 3MD simulation plots for checking the overall stability of the systems during 100 ns. (A) Potential energy profile of PDE5 in the presence of sildenafil and β-amyrin. (B) RMSD profile of PDE5 in the presence of sildenafil and β-amyrin. (C) RMSF of simulated complexes of PDE5 with sildenafil and β-amyrin. (D) Radius of gyration of PDE5 with bound sildenafil and β-amyrin. The figure was drawn using Microsoft Excel 2016.
Figure 4Effect of S. mangifera fruit extract on mount frequency (n = 6). The values are means ± SEM; * p < 0.05, ** p < 0.1; ns p > 0.05 (followed by Student Dunnett test).
Figure 5Effect of S. mangifera fruit extract on mount latency (n = 6). The values are means ± SEM; * p < 0.05, ** p < 0.1; ns p > 0.05 (followed by Student Dunnett test).
Figure 6Effect of S. mangifera fruit extract on intromission frequency (n = 6). The values are means ± SEM; * p < 0.05, ** p < 0.1; ns p > 0.05 (followed by Student Dunnett test).
Figure 7Effect of S. mangifera fruit extract on intromission latency (n = 6). The values are means ± SEM; * p < 0.05, ** p < 0.1; ns p > 0.05 (followed by Student Dunnett test).
Figure 8Effect of S. mangifera fruit extract on ejaculation frequency (n = 6). The values are means ± SEM; * p < 0.05, ** p < 0.1; ns p > 0.05 (followed by Student Dunnett test).
Figure 9Effect of S. mangifera fruit extract on ejaculation latency (n = 6). The values are means ± SEM; * p < 0.05, ** p < 0.1; ns p > 0.05 (followed by Student Dunnett test).
Figure 10Effects of SMFE on phosphodiesterase level (n = 6). The values are means ± SEM; * p < 0.05, ** p < 0.1; ns p > 0.05.
Figure 11Effect of S. mangifera fruit extract on testosterone level (n = 6). The values are means ± SEM; * p < 0.05, ** p < 0.1; ns p > 0.05 (followed by Student Dunnett test).
Figure 12Effect of S. mangifera fruit extract on NO level (n = 6). The values are means ± SEM; * p < 0.05, ** p < 0.1; ns p > 0.05 (followed by Student Dunnett test).
Figure 13The possible mechanism of smooth muscle relaxation through PDE5 inhibition.